BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-2,333 Cr | ₹13,049 Cr | ₹242 Cr | ₹2,564 Cr | ₹388 Cr |
What is the latest Cash Flow from Financing Activities ratio of BIOCON ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-2,333 Cr |
Mar2023 | ₹13,049 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹2,564 Cr |
Mar2020 | ₹388 Cr |
How is Cash Flow from Financing Activities of BIOCON Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,333 Cr | Negative | |
Mar2023 | ₹13,049 Cr | 5,289.80 | |
Mar2022 | ₹242 Cr | -90.56 | |
Mar2021 | ₹2,564 Cr | 561.51 | |
Mar2020 | ₹388 Cr | - |
Compare Cash Flow from Financing Activities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹41,594.8 Cr | -1.1% | -1.8% | 40.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -1.1% |
-1.8% |
40.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses